Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in the preparation of active pharmaceutical ingredients (APIs) targeting epidermal growth factor receptor (EGFR) and other tyrosine kinases. Its structure allows for selective modification, enabling optimization of drug potency and selectivity. Also employed in research settings for generating compound libraries in drug discovery programs.